Content Block Tag: NRG-HN014: Immunotherapy for Advanced Skin Cancer

‘Text/HTML’ of page ‘NRG-HN014: Immunotherapy for Advanced Skin Cancer’

Am I eligible for this study? People who have advanced skin cancer and are able to receive surgery for their cancer may be eligible for the study. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss […]

‘Text/HTML’ of page ‘NRG-HN014: Immunotherapy for Advanced Skin Cancer’

About This Study NRG-HN014 is a clinical study that will be testing if adding the immunotherapy drug called “Cemiplimab” (REGN2810) prior to surgery can extend the length of time without your cancer returning for people with advanced skin cancer. Typically, patients with this type of cancer are treated with surgery first and, depending the […]

‘Text/HTML’ of page ‘NRG-HN014: Immunotherapy for Advanced Skin Cancer’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-HN014: Immunotherapy for Advanced Skin Cancer’

The NRG-HN014 Study FAQ